危重症成人延迟肠外营养对2年死亡率和功能结局的影响
该研究为多中心EPaNIC随机对照试验的前瞻性随访研究,纳入危重症成人,比较延迟肠外营养(入ICU 1周后,Late-PN)与早期补充肠外营养(Early-PN)对2年死亡率(N=4640)和身体功能(SF-36,3292名存活者,随机化后819[738-1058]天应答)的影响。结果显示2年死亡率Late-PN组20.5% vs Early-PN组19.8%(P=0.54),身体功能两组均为70[40-90](P=0.99),缺失数据插补后结果相似;各营养风险亚组中Late-PN均无影响;PCS和MCS两组相似。结论为Late-PN不改变危重症成人2年生存和身体功能,与预估营养风险无关。
要点
- 危重症成人延迟至入ICU 1周后给予肠外营养(Late-PN)与早期补充肠外营养(Early-PN)相比,2年死亡率20.5% vs 19.8%(P=0.54),无显著差异。
- 2年身体功能(SF-36)两组均为70[40-90](P=0.99),缺失数据插补后结果相似。
- 按NRS-2002评分、mNUTRIC评分及年龄(>70岁/≤70岁)划分的营养风险亚组中,Late-PN对2年死亡率和身体功能均无影响。
- SF-36衍生的躯体组分评分(PCS)和精神组分评分(MCS)两组相似。
- 该研究为EPaNIC随机对照试验的前瞻性随访,样本量2年死亡率分析N=4640,身体功能分析3292名存活者。
适用人群与场景
- 危重症成人,来自多中心EPaNIC随机对照试验人群。
- 2年死亡率分析N=4640;身体功能分析为3292名存活者,于随机化后819[738-1058]天应答SF-36。
研究设计与关键结果
- 研究类型:多中心EPaNIC随机对照试验的前瞻性随访研究。
- 干预与对照:延迟肠外营养(Late-PN,入ICU 1周后)vs 早期补充肠外营养(Early-PN)。
- 主要终点:2年死亡率Late-PN组20.5% vs Early-PN组19.8%(P=0.54);身体功能(SF-36)两组均为70[40-90](P=0.99);缺失身体功能数据插补后结果相似。
- 营养风险亚组:按NRS-2002评分、mNUTRIC评分及年龄(>70岁/≤70岁)划分,Late-PN对2年死亡率和身体功能均无影响,亚组与干预效应间无统计学显著交互作用。
- 次要终点:SF-36衍生的PCS和MCS两组相似。
证据类型、等级与局限
- 证据类型:多中心随机对照试验(EPaNIC)的前瞻性随访研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于危重症成人,延迟至入ICU 1周后给予肠外营养不改变2年死亡率和身体功能,与预估营养风险无关(EPaNIC试验前瞻性随访结果)。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: In critically ill adults, withholding parenteral nutrition until 1 week after intensive care admission (Late-PN) facilitated recovery as compared with early supplementation of insufficient enteral nutrition with parenteral nutrition (Early-PN). However, the impact on long-term mortality and functional outcome, in relation to the estimated nutritional risk, remains unclear.
METHODS: In this prospective follow-up study of the multicenter EPaNIC randomized controlled trial, we investigated the impact of Late-PN on 2-year mortality (N = 4640) and physical functioning, assessed by the 36-Item Short Form Health Survey (SF-36; in 3292 survivors, responding 819 [738-1058] days post-randomization). To account for missing data, we repeated the analyses in two imputed models. To identify potential heterogeneity of treatment effects, we investigated the impact of Late-PN in different nutritional risk subgroups as defined by Nutritional Risk Screening-2002-score, modified NUTrition Risk in the Critically Ill-score, and age (above/below 70 years), and we evaluated whether there was statistically significant interaction between classification to a nutritional risk subgroup and the effect of the randomized intervention. Secondary outcomes were SF-36-derived physical and mental component scores (PCS & MCS).
RESULTS: Two-year mortality (20.5% in Late-PN, 19.8% in Early-PN; P = 0.54) and physical functioning (70 [40-90] in both study-arms; P = 0.99) were similar in both groups, also after imputation of missing physical functioning data. Likewise, Late-PN had no impact on 2-year mortality and physical functioning in any nutritional risk subgroup. PCS and MCS were similar in both groups.
CONCLUSION: Late-PN did not alter 2-year survival and physical functioning in adult critically ill patients, independent of anticipated nutritional risk.
参考来源
- Casaer MP, Stragier H, Hermans G, et al. Impact of withholding early parenteral nutrition on 2-year mortality and functional outcome in critically ill adults. Intensive Care Med. 2024. PMID: 39017697. doi:10.1007/s00134-024-07546-w
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。